Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

International Stem Cell Corp

+ Add to Watchlist

ISCO:US

0.0500 USD 0.00000.00%

As of 20:10:01 ET on 05/22/2015.

Snapshot for International Stem Cell Corp (ISCO)

Open: 0.0499 Day's Range: 0.0499 - 0.0500 Volume: 767,607
Previous Close: 0.0500 52wk Range: 0.0450 - 0.1589 1-Yr Rtn: -66.44%

Stock Chart for ISCO

No chart data available.
  • ISCO:US 0.0500
  • 1D
  • 1M
  • 1Y
0.0500
Interactive ISCO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ISCO

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.0700
Est. EPS (USD) (12/2015) -
Est. PEG Ratio -
Market Cap (M USD) 13.54
Shares Outstanding (M) 270.72
30 Day Average Volume 962,452
Price/Book (mrq) -
Price/Sale (ttm) 1.4817
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ISCO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ISCO

International Stem Cell Corporation develops therapeutic and research products in the biotechnology industry. The Company seeks to use human cells for use in the treatment of several diseases including diabetes, as well as in liver and retinal diseases.

Andrey SemechkinCo-Chairman/CEORuslan SemechkinChief Scientific Officer
John Simon CrawExec VP:Bus DevSofya BakalovaVP:Legal Affairs & Operations
More Company Profile & Key Executives for ISCO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil